跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DUKORAL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DUKORAL
Authorized
STANDARD
DUKORAL
Valneva Sweden AB
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e72f263ab83b7f15
Company
Valneva Sweden AB
Type
Standard
Approval Details
Approval Id
e72f263ab83b7f15
Drug Approval Canada Name
DUKORAL
Product Name
DUKORAL
Status
Marketed
Status Date
2011-08-15
Original Market Date
2003-04-15
Din
02247208
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Oral
Schedule
Schedule D
Ahfs
80:12.00
Atc Original
J07AE01 CHOLERA, INACTIVATED, WHOLE CELL
Atc Name
j 07 ae 01
Aig Number
0548981004
Company Name
Valneva Sweden AB
Company Address
Gunnar Asplunds Allé 16, Stockholm, --, Sweden, 10521
Company Detail Path
/organization/valneva-sweden-ab
Company Information
Pharmaceutical Company Name
Valneva Sweden AB
Country Name
Sweden
Province Name
stockholm,country_se
City Name
solna,stockholm,country_se
Address
Terminalvägen 4
Website
http://www.valneva.com/en/company/sweden
Active Ingredients
RECOMBINANT CHOLERA TOXIN B SUBUNIT
1 MG / DOSE
VIBRIO CHOLERAE INABA 48 CLASSICAL BIOTYPE, HEAT INACTIVATED
31250000000 CELLS / DOSE
VIBRIO CHOLERAE INABA 6973 EL TOR BIOTYPE, FORMALIN INACTIVATED
31250000000 CELLS / DOSE
VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, HEAT INACTIVATED
31250000000 CELLS / DOSE
VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, FORMALIN INACTIVATED
31250000000 CELLS / DOSE
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e72f263ab83b7f15
Type
Standard
Back to Health Canada Approvals
